Portfolio company
Relation Therapeutics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biotechnology firm develops an artificial intelligence platform to identify and validate therapeutic drug targets for pharmaceutical companies and research partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Relation
This company develops an artificial intelligence platform to identify drug targets for pharmaceutical partners and its own pipeline of medicines.
Biorelate
This company develops an artificial intelligence platform that curates biomedical data to support drug discovery for pharmaceutical and life sciences organisations.
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
Iambic Therapeutics
This company develops artificial intelligence platforms for drug discovery and clinical-stage therapeutics for biopharmaceutical partners and healthcare sectors.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
Envisagenics
This biotechnology company develops an artificial intelligence platform to identify drug targets from RNA splicing data for pharmaceutical and biopharmaceutical organisations.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
